Sun Pharma to sell second brand of Bayer kidney drug finerenone in India

Sun Pharmaceutical Industries Ltd and Bayer have signed an agreement to market and distribute a second brand of finerenone in the country. Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second brand of finerenone named Lyvelsa.Kirti Ganorkar, CEO of India Business at Sun Pharma, said, “We are happy to collaborate with Bayer to provide patients access to a new treatment which slows down the progression of chronic kidney disease and reduces the risk of kidney failure associated with Type-2 diabetes. This partnership underscores our commitment to make innovative medicines available to patients in India.” Shweta Rai, Country Division Head (CDH) for Bayer’s Pharmaceuticals Business in South Asia, said, “With the introduction of a second brand of finerenone in India, through our partnership with Sun Pharma, we are advancing Bayer’s commitment of making healthcare accessible to as many patients as possible.”

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!